2022
DOI: 10.2147/cmar.s352334
|View full text |Cite
|
Sign up to set email alerts
|

A Pilot Study of Prognostic Value of Metastatic Lymph Node Count and Size in Patients with Different Stages of Gastric Carcinoma

Abstract: Background The correlation between the preoperative lymph node count (LNC) on multidetector computed tomography (MDCT) and the prognosis of gastric carcinoma (GC) remains to be defined. This research aims to evaluate the prognostic value of LNC on MDCT in GC patients based on tumor-node-metastasis (TNM) staging, using different size criteria for counting. Methods The clinical data of 126 patients with gastric adenocarcinoma undergoing gastrectomy were retrospectively an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 28 publications
0
1
0
1
Order By: Relevance
“…Hal tersebut biasanya terjadi karena pertumbuhan dari pembuluh dara yang terjadi secara berlebihan (proliferasi). Perubahan warna tersebut terjadi disebabkan oleh pembuluh darah yang berada di permukaan kuluiit semakin melebar dan tak jarang juga memiliki warna keunguan jika kondisi tersebut terjadi di lapisan dalam pada pembuluh darah [6]. Kondisi tersebut disebut dengan hemangioma.…”
Section: Pendahuluanunclassified
“…Hal tersebut biasanya terjadi karena pertumbuhan dari pembuluh dara yang terjadi secara berlebihan (proliferasi). Perubahan warna tersebut terjadi disebabkan oleh pembuluh darah yang berada di permukaan kuluiit semakin melebar dan tak jarang juga memiliki warna keunguan jika kondisi tersebut terjadi di lapisan dalam pada pembuluh darah [6]. Kondisi tersebut disebut dengan hemangioma.…”
Section: Pendahuluanunclassified
“…The treatment response is evaluated according to the response evaluation criteria in solid tumors (RECIST), which mainly assesses the changes of tumor size on computed tomography (CT) [ 1 , 2 ]. Nonetheless, the size of tumor changes lagging than biological and molecular levels [ 3 , 4 ]. Therefore, explorations of reliable surrogate markers that can indicate treatment response are warranted.…”
Section: Introductionmentioning
confidence: 99%